Kyle Mikson
Stock Analyst at Canaccord Genuity
(0)
# 4912
Out of 5,348 analysts
101
Total ratings
19.64%
Success rate
-26.49%
Average return
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
AKYA Akoya Biosciences | Maintains: Hold | 2 2 | 1.24 | -12.9% | 5 | May 19, 2025 | |
GRAL GRAIL | Maintains: Strong Buy | 32 43 | 37.47 | 14.76% | 2 | May 14, 2025 | |
BDSX Biodesix | Maintains: Buy | 3 2 | 0.31 | 383.87% | 4 | May 14, 2025 | |
XGN Exagen | Maintains: Strong Buy | 7 8 | 7.14 | 12.04% | 3 | May 13, 2025 | |
QTRX Quanterix | Maintains: Buy | 15 12 | 5.24 | 129.01% | 6 | May 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 18 15 | 9.47 | 58.39% | 8 | May 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 92 87 | 81.05 | 7.34% | 10 | May 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 42 37 | 16.2 | 128.4% | 4 | May 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 60 65 | 42.07 | 54.5% | 6 | May 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 170 150 | 118.5 | 26.58% | 3 | Apr 16, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 3 3 | 0.99 | 203.03% | 8 | Apr 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 180 195 | 160.22 | 21.71% | 8 | Feb 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 3 3 | 1.26 | 138.1% | 4 | Nov 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 2 1 | 1.68 | -40.48% | 3 | Nov 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 95 75 | 56.07 | 33.76% | 9 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 3 5 | n/a | n/a | 3 | Jul 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | 26 | n/a | n/a | 2 | Mar 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 2 | n/a | n/a | 4 | Nov 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 3 | n/a | n/a | 4 | Sep 25, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 3 2 | 0.52 | 284.62% | 2 | Aug 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 50 | 0.61 | 7965.57% | 1 | Mar 30, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 19 | 3.88 | 389.69% | 1 | Jan 29, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 150 | n/a | n/a | 1 | Jan 29, 2021 |